B Wolozin
Overview
Explore the profile of B Wolozin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1672
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Solomon A, Sippola R, Soininen H, Wolozin B, Tuomilehto J, Laatikainen T, et al.
Neurodegener Dis
. 2010 Mar;
7(1-3):180-2.
PMID: 20224281
Background: Several lines of evidence have linked cholesterol to dementia. Objective: To investigate lipid-lowering drug use and dementia development in a Finnish population. Methods: FINRISK is a large population-based survey...
2.
Hsu C, Chan D, Wolozin B
Neurodegener Dis
. 2010 Feb;
7(1-3):68-75.
PMID: 20173330
Increasing evidence supports a putative link between LRRK2 function and the MAP kinase cascades. We recently demonstrated that LRRK2 binds to MKK6, -3, and -7. Previous studies demonstrated that scaffold...
3.
Solomon A, Kareholt I, Ngandu T, Wolozin B, Macdonald S, Winblad B, et al.
Neurobiol Aging
. 2007 Nov;
30(6):1006-9.
PMID: 18022292
Background: The association between serum total cholesterol (TC), lipid-lowering drugs and cognition in the elderly is currently controversial. Objective: To investigate the relationship between TC, lipid-lowering drugs and cognitive functions...
4.
Wolozin B, Manger J, Bryant R, Cordy J, Green R, McKee A
Acta Neurol Scand Suppl
. 2006 Jul;
185:63-70.
PMID: 16866913
This communication integrates the purported role of cholesterol and statins in Alzheimer's disease (AD) with recent data. Meta-analysis of association studies relevant to AD indicates that apolipoprotein (apo)E4 is the...
5.
Bednar M, Lee T, Wolozin B, Weiss K
Neurology
. 2006 Jun;
66(11):1785.
PMID: 16769972
No abstract available.
6.
Frasier M, WALZER M, McCarthy L, Magnuson D, Lee J, Haas C, et al.
Exp Neurol
. 2005 Mar;
192(2):274-87.
PMID: 15755545
Mice overexpressing mutant alpha-synuclein develop a progressive loss of motor function associated with the accumulation of aggregated alpha-synuclein in neurons of the brainstem. Recent reports suggest that tau pathology might...
7.
Choi P, Snyder H, Petrucelli L, Theisler C, Chong M, Zhang Y, et al.
Brain Res Mol Brain Res
. 2003 Oct;
117(2):179-89.
PMID: 14559152
Mutations in parkin are associated with various inherited forms of Parkinson's disease (PD). Parkin is a ubiquitin ligase enzyme that catalyzes the covalent attachment of ubiquitin moieties onto substrate proteins...
8.
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology
Pappolla M, Bryant-Thomas T, Herbert D, Pacheco J, Fabra Garcia M, Manjon M, et al.
Neurology
. 2003 Jul;
61(2):199-205.
PMID: 12874399
Background: Epidemiologic and experimental data suggest that cholesterol may play a role in the pathogenesis of AD. Modulation of cholesterolemia in transgenic animal models of AD strongly alters amyloid pathology....
9.
Wolozin B
Biochem Soc Trans
. 2002 Aug;
30(4):525-9.
PMID: 12196129
Accumulation of a 40-42-amino acid peptide, termed amyloid-beta peptide (A beta), is associated with Alzheimer's disease (AD), and identifying medicines that inhibit A beta could help patients with AD. Recent...
10.
Choi P, Golts N, Snyder H, Chong M, Petrucelli L, Hardy J, et al.
Neuroreport
. 2001 Oct;
12(13):2839-43.
PMID: 11588587
Parkin and alpha-synuclein are two proteins that are associated with the pathophysiology of Parkinson's disease (PD). Parkin is present in Lewy bodies and axonal spheroids in brains affected by PD,...